+
Education

The very real story of how one woman prevented a national tragedy by doing her job

Frances Oldham Kelsey believed thorough research saves lives. She was so right.

dr. frances oldham kelsey, john f. kennedy, thalomid
Image by the U.S. Food and Drug Administration.

Dr. Frances Oldham Kelsey and President John F. Kennedy.

True
Seventh Generation

This story originally appeared on 05.20.16


Dr. Frances Oldham Kelsey had only been with the Food and Drug Administration for about a month when she was tasked with reviewing a drug named thalidomide for distribution in America.

Marketed as a sedative for pregnant women, thalidomide was already available in Canada, Germany, and several African countries.


It could have been a very simple approval. But for Kelsey, something didn't sit right. There were no tests showing thalidomide was safe for human use, particularly during pregnancy.

thalidomide, wonder drug, public health

Kelsey in her office at the FDA in 1960.

Image by the U.S. Food and Drug Administration.

When Chemie Grünenthal released thalidomide in West Germany years earlier, they called it a "wonder drug" for pregnant women. They promised it would treat anxiety, insomnia, tension, and morning sickness and help pregnant women sleep.

What they didn't advertise were its side effects.

Because it crosses the placental barrier between fetus and mother, thalidomide causes devastating — often fatal — physical defects. During the five years it was on the market, an estimated 10,000 babies globally were born with thalidomide-caused defects. Only about 60% lived past their first birthday.

In 1961, the health effects of thalidomide weren't well-known. Only a few studies in the U.K. and Germany were starting to connect the dots between babies born with physical defects and the medication their mothers had taken while pregnant.

At the outset, that wasn't what concerned Kelsey. She'd looked at the testimonials in the submission and found them "too glowing for the support in the way of clinical back up." She pressed the American manufacturer, Cincinnati's William S. Merrell Company, to share research on how their drug affected human patients. They refused. Instead, they complained to her superiors for holding up the approval. Still, she refused to back down.

drugs, medication, medicine

A sample pack of thalidomide.

Image by Stephen C. Dickson/Wikimedia Commons.

A sample pack of thalidomide sent to doctors in the U.K. While more than 10,000 babies worldwide were born with thalidomide-related birth defects, FDA historian John Swann credits Dr. Kelsey with limiting the number of American babies affected to just 17.

Over the next year, the manufacturer would resubmit its application to sell thalidomide six times. Each time, Kelsey asked for more research. Each time, they refused.

By 1961, thousands of mothers were giving birth to babies with shocking and heartbreaking birth defects. Taking thalidomide early in their pregnancy was the one thing connecting them. The drug was quickly pulled from shelves, vanishing mostly by 1962.

Through dogged persistence, Kelsey and her team had prevented a national tragedy.

government, FDA, bureaucracy, community

Kelsey joins President John F. Kennedy at the signing of a new bill expanding the authority of the FDA in 1962.

Image by the U.S. Food and Drug Administration.

In 1962, President John F. Kennedy honored Kelsey with the Federal Civilian Service Medal. He thanked her for her exceptional judgment and for preventing a major tragedy of birth deformities in the United States:

“I know that we are all most indebted to Dr. Kelsey. The relationship and the hopes that all of us have for our children, I think, indicate to Dr. Kelsey, I am sure, how important her work is and those who labor with her to protect our families. So, Doctor, I know you know how much the country appreciates what you have done."

But, she wasn't done yet. Later that year, the FDA approved new, tougher regulations for companies seeking drug approval, inspired in large part by Kelsey's work on thalidomide.

Reached via email, FDA historian John Swann said this about Kelsey's legacy: "[Her] actions also made abundantly clear to the nation the important public health role that drug regulation and FDA itself play in public health. The revelation of the global experience with that drug and America's close call indeed provided impetus to secure passage of a comprehensive drug regulation bill that had been more or less floundering during the time FDA was considering the application."

Kelsey continued to work for the FDA until 2005. She died in 2015, aged 101, just days after receiving the Order of Canada for her work on thalidomide.

Bureaucratic approval work is rarely thrilling and not often celebrated. That's a shame because it's so critical.

People like Kelsey, who place public health and safety above all else — including their career — deserve every ounce of our collective respect and admiration.

Joy

Sorry, Labradors. After 31 years, America has a new favorite dog.

The American Kennel Club has crowned a new favorite.

via Pixabay

A sad-looking Labrador Retriever

The sweet-faced, loveable Labrador Retriever is no longer America’s favorite dog breed. The breed best known for having a heart of gold has been replaced by the smaller, more urban-friendly French Bulldog.

According to the American Kennel Club, for the past 31 years, the Labrador Retriever was America’s favorite dog, but it was eclipsed in 2022 by the Frenchie. The rankings are based on nearly 716,500 dogs newly registered in 2022, of which about 1 in 7 were Frenchies. Around 108,000 French Bulldogs were recorded in the U.S. in 2022, surpassing Labrador Retrievers by over 21,000.

Keep ReadingShow less
@morgvn.elizabeth/TikTok

Hip-hop Irish dancing is kind of the coolest thing ever.

If you somehow missed Irish dance extraordinaire and viral sensation Morgan Bullock, you’re in for a treat.

Back in 2020, the then 20-year-old performer posted a video of her jigging to a remixed version of Megan Thee Stallion’s “Savage,” also featuring the vocals of Beyoncé. As the internet is wont to fawn over unexpected mashups, it’s no wonder that the clip sent folks into a frenzy online.

Keep ReadingShow less
Joy

An 8-year-old snuck his handwritten book onto a library shelf. Now it has a 56-person waiting list.

Dillon Helbig's 81-page graphic novel— written by "Dillon His Self"—captured the hearts of his local librarians and their patrons.

Dillon Helbig's 81-page graphic novel captured the hearts of his local librarians.

Writing a book is no easy task, even for adult professional writers. Many would-be authors dream of a day when their work can be found on library shelves, unsure if it will ever come.

But for 8-year-old Dillon Helbig, that day has already arrived—in truly unconventional fashion—thanks to his own determination to make it happen.

Dillon wrote his 81-page graphic novel, "The Adventures of Dillon Helbig's Crismis" (written by "Dillon His Self") in a hardcover journal with colored pencils over the course of a few days. He even put a label on the back of the book that reads "Made in Idho" [sic] and put an illustrated spine label on it as well. Then, without telling anyone, he brought it to his local library in Boise, Idaho, and slipped it in among the books in the children's section.

Keep ReadingShow less

The Cure at Southside Festival 2019

Robert Smith of The Cure was already a hero to five decades of disaffected youth, including the creators of “South Park,” but now everyone has a reason to love the “Close to Me” singer. He got Ticketmaster to admit it was gouging customers and got them a refund.

The Cure went out of its way to ensure that ticket prices to its upcoming North American tour were affordable to the average fan by selling them as low as $20. The band also used Ticketmaster’s “verified fan” process to cut down on scalpers and prevent fans from having to pay inflated prices on resale sites.

But the band had no power over the egregious fees that Ticketmaster tacks on to every sale. The band wouldn't agree to dynamic pricing—where ticket prices fluctuate based on demand—so it appears as though Ticketmaster simply raised its fees per ticket.

Keep ReadingShow less

Two northern cardinals captured on Carla Rhodes' bird-feeder camera.

The pandemic has caused many people to reevaluate their surroundings. When you’re stuck at home more often than you’d like, you start to pay a lot more attention to what goes on in your own backyard.

This type of introspection inspired wildlife photographer Carla Rhodes to get a closer look at the furry friends that live near her home in the Catskill mountains of New York.

What she found was magical.

“The winter of 2020-2021 was particularly brutal to humankind. After months of enduring the Covid-19 pandemic, we were now collectively slogging through winter. As a result of being stuck at home, I focused on my immediate surroundings like never before,” Rhodes said in a statement.

Keep ReadingShow less
Identity

57-year-old former model Paulina Porizkova had the perfect response to ageist comment online

"We have earned our beauty, we understand what it is, and we can see it so much better."

Photo by Malin K. on Unsplash

Paulina Porizkova took on a commenter who said she was in "pain" being "old and ugly."

Aging is a weird thing. From one perspective, it's something we should be grateful for. Few people would wish for the kind of short, uneventful life that would remove aging from the equation completely. The longer we live, the more we grow and learn and experience life, and "aging" is simply the mathematical sum of those experiences. All good, right?

On the other hand, our society does everything in its power to hide the fact that aging happens. Especially when it comes to women. According to Statista, the global anti-aging beauty market is estimated to be worth $58.8 billion. People will try all manner of creams, serums, masks, acids, lights, technologies and surgeries to try to prevent wrinkles, lines, sagginess, spots and other signs that our bodies are changing with time.

Most of us live our daily lives somewhere in the middle of these two realities, wanting to embrace our aging selves but also hoping to stave off some of the more obvious signs that we're getting older. It's natural to resist it in some ways, since the older we get, the closer we get to the end of our lives, which we certainly don't want to hasten—especially if we actually love living.

It can be helpful to see people who are embracing their age, which is why it can be inspiring to see someone like former supermodel Paulina Porizkova confidently sharing photos of her 57-year-old self.

Keep ReadingShow less